Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)

Overview of attention for article published in Annals of Hematology, October 2014

Altmetric Badge

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Dimensions citations

So far, Dimensions has found 35 publications that cite this research output.

35

The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.

Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis

Article in Journal of Hematology (October 2023)

Treatment of extranodal NK/T-cell lymphoma: From past to future

Article in Frontiers in Immunology (February 2023)

Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy

Article in Clinical and Translational Radiation Oncology (November 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.